{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:42:52Z","timestamp":1789382572793,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1053\/j.seminhematol.2013.11.003","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T04:08:01Z","timestamp":1385006881000},"page":"5-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Pathology of Peripheral T-Cell Lymphomas: Where Do We Stand?"],"prefix":"10.1053","volume":"51","author":[{"given":"Philippe","family":"Gaulard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2013.11.003_bib1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Armitage","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib3","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib4","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib5","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","article-title":"Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation","volume":"35","author":"Garcia-Herrera","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib6","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK-negative anaplastic large-cell lymphoma (ALCL) is clinically and immunophenotypically different from both ALK-positive ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib7","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2012.42.2345","article-title":"Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials","volume":"30","author":"Sibon","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib8","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","article-title":"Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study","volume":"29","author":"Lamant","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib9","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3324\/haematol.2009.021428","article-title":"Disturbed expression of the T-cell receptor\/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations","volume":"10","author":"Geissinger","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","article-title":"CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features","volume":"98","author":"Bisig","year":"2013","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2040620712471553","article-title":"The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update","volume":"4","author":"Lai","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3324\/haematol.2009.015024","article-title":"Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases","volume":"95","author":"Lamant","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib13","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","article-title":"Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas","volume":"140","author":"Salaverria","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib15","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","article-title":"Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes","volume":"109","author":"Lamant","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib16","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms","volume":"28","author":"Piva","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2012.38","article-title":"Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"25","author":"Sciallis","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib23","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3324\/haematol.2010.026237","article-title":"Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity","volume":"95","author":"Thompson","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib24","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/PAS.0b013e31825749b1","article-title":"Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases","volume":"36","author":"Aladily","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.semdp.2011.03.003","article-title":"Follicular helper T cells: implications in neoplastic hematopathology","volume":"28","author":"Gaulard","year":"2011","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2559.2011.04022.x","article-title":"c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis","volume":"60","author":"Bisig","year":"2012","journal-title":"Histopathology"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":"Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression","volume":"31","author":"Attygalle","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","article-title":"Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist","volume":"37","author":"Nicolae","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib31","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib32","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib34","first-page":"330A","article-title":"Novel fusion transcripts identified in angioimmunoblastic T cell lymphoma","volume":"26","author":"Guo","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000478-200103000-00015","article-title":"Peripheral T-cell lymphoma with follicular involvement and a CD4+\/bcl-6+ phenotype","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib37","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","article-title":"Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics","volume":"36","author":"Moroch","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20092042","article-title":"The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma","volume":"207","author":"Pechloff","year":"2010","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodriguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/AJCP83AOQTMLOJTM","article-title":"Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Quintanilla-Martinez","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib42","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers","volume":"32","author":"Rodriguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib44","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAS.0b013e318275d1a2","article-title":"TCR-gamma expression in primary cutaneous T-cell lymphomas","volume":"37","author":"Rodriguez-Pinilla","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib46","first-page":"1723","article-title":"Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization","volume":"91","author":"Arnulf","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib47","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib48","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood.V90.10.4099","article-title":"The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease","volume":"90","author":"Teruya-Feldstein","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib49","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib50","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib51","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/leu.2009.91","article-title":"STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK\/T-cell lymphoma","volume":"23","author":"Coppo","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.critrevonc.2010.06.006","article-title":"Enteropathy-associated T-cell lymphoma","volume":"79","author":"Ferreri","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/his.12251","article-title":"Peripheral T- and NK-cell lymphomas and their mimics: taking a step forward\u2014report on the Lymphoma Workshop of the XVI meeting of the European Association for Haematopathology in Lisbon 2012","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib54","first-page":"493","article-title":"Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma","volume":"151","author":"Ashton-Key","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib55","first-page":"203","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma","volume":"356","author":"Cellier","year":"2000","journal-title":"French Coeliac Disease Study Group. Lancet"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib56","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib58","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","article-title":"Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology","volume":"153","author":"Chott","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib59","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","article-title":"Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression","volume":"35","author":"Chan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib60","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/00000478-199910000-00008","article-title":"Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection","volume":"23","author":"Quintanilla-Martinez","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib61","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","article-title":"Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study","volume":"108","author":"Dupuis","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib62","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00428-004-1077-2","article-title":"Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells","volume":"445","author":"Geissinger","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib63","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beha.2012.01.004","article-title":"New biomarkers in T-cell lymphomas","volume":"25","author":"Bisig","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.003_bib65","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196313001534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196313001534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:22:10Z","timestamp":1758522130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196313001534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0037196313001534"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2013.11.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology of Peripheral T-Cell Lymphomas: Where Do We Stand?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2013.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}